CN107898866A - 一种治疗皮肌炎的中药制剂及其制备方法 - Google Patents
一种治疗皮肌炎的中药制剂及其制备方法 Download PDFInfo
- Publication number
- CN107898866A CN107898866A CN201711297308.7A CN201711297308A CN107898866A CN 107898866 A CN107898866 A CN 107898866A CN 201711297308 A CN201711297308 A CN 201711297308A CN 107898866 A CN107898866 A CN 107898866A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- preparation
- dermatomyositis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 83
- 238000002360 preparation method Methods 0.000 title claims abstract description 58
- 201000001981 dermatomyositis Diseases 0.000 title claims abstract description 35
- MUKYLHIZBOASDM-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid 2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound NC(=N)N(C)CC(O)=O.OCC(O)C(O)C(O)C(O)C(O)=O MUKYLHIZBOASDM-UHFFFAOYSA-N 0.000 claims abstract description 24
- 241001533104 Tribulus terrestris Species 0.000 claims abstract description 24
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 23
- 229910052602 gypsum Inorganic materials 0.000 claims abstract description 23
- 239000010440 gypsum Substances 0.000 claims abstract description 23
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 22
- 241000951473 Schizonepeta Species 0.000 claims abstract description 22
- 206010043866 Tinea capitis Diseases 0.000 claims abstract description 20
- 208000009189 tinea favosa Diseases 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 16
- 241000219781 Pueraria montana var. lobata Species 0.000 claims abstract 7
- 239000007788 liquid Substances 0.000 claims description 32
- 238000009835 boiling Methods 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 11
- 239000002775 capsule Substances 0.000 claims description 10
- 239000004744 fabric Substances 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 10
- 239000012535 impurity Substances 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000007654 immersion Methods 0.000 claims description 5
- 238000012545 processing Methods 0.000 claims description 5
- 230000002070 germicidal effect Effects 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 238000007873 sieving Methods 0.000 claims description 4
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims 2
- 229910052737 gold Inorganic materials 0.000 claims 2
- 239000010931 gold Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 229910052709 silver Inorganic materials 0.000 claims 2
- 239000004332 silver Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 25
- 206010037660 Pyrexia Diseases 0.000 abstract description 15
- 201000010099 disease Diseases 0.000 abstract description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 12
- 210000003205 muscle Anatomy 0.000 abstract description 12
- 229940079593 drug Drugs 0.000 abstract description 10
- 230000001717 pathogenic effect Effects 0.000 abstract description 10
- 230000001737 promoting effect Effects 0.000 abstract description 10
- 208000008454 Hyperhidrosis Diseases 0.000 abstract description 8
- 231100000331 toxic Toxicity 0.000 abstract description 8
- 230000002588 toxic effect Effects 0.000 abstract description 8
- 208000013219 diaphoresis Diseases 0.000 abstract description 6
- 230000001939 inductive effect Effects 0.000 abstract description 5
- 238000010926 purge Methods 0.000 abstract description 4
- 241000721047 Danaus plexippus Species 0.000 abstract description 3
- 230000035876 healing Effects 0.000 abstract description 3
- 208000002193 Pain Diseases 0.000 description 19
- 244000046146 Pueraria lobata Species 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 10
- 206010030113 Oedema Diseases 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 206010019233 Headaches Diseases 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 206010015150 Erythema Diseases 0.000 description 7
- 231100000321 erythema Toxicity 0.000 description 7
- 210000003414 extremity Anatomy 0.000 description 7
- 231100000869 headache Toxicity 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 208000000112 Myalgia Diseases 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 230000035922 thirst Effects 0.000 description 6
- 241000208340 Araliaceae Species 0.000 description 5
- 201000005505 Measles Diseases 0.000 description 5
- 206010028372 Muscular weakness Diseases 0.000 description 5
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 description 5
- 230000001154 acute effect Effects 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 235000008434 ginseng Nutrition 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 210000003800 pharynx Anatomy 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 4
- 206010033733 Papule Diseases 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- 208000035861 hematochezia Diseases 0.000 description 4
- 238000005057 refrigeration Methods 0.000 description 4
- 238000007789 sealing Methods 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010025421 Macule Diseases 0.000 description 3
- 244000061458 Solanum melongena Species 0.000 description 3
- 208000002474 Tinea Diseases 0.000 description 3
- 241000130764 Tinea Species 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 206010046788 Uterine haemorrhage Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 206010000269 abscess Diseases 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 239000003018 immunosuppressive agent Substances 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 3
- 230000036473 myasthenia Effects 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 201000005404 rubella Diseases 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 206010044565 Tremor Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003444 anaesthetic effect Effects 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000476 body water Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- 210000000744 eyelid Anatomy 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 206010036067 polydipsia Diseases 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 210000000697 sensory organ Anatomy 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 101100276976 Drosophila melanogaster Drak gene Proteins 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010015237 Erythema of eyelid Diseases 0.000 description 1
- 206010052140 Eye pruritus Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010016326 Feeling cold Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010021703 Indifference Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 206010028629 Myoglobinuria Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000033952 Paralysis flaccid Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010039020 Rhabdomyolysis Diseases 0.000 description 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 244000297179 Syringa vulgaris Species 0.000 description 1
- 235000004338 Syringa vulgaris Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 206010044684 Trismus Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 235000001667 Vitex agnus castus Nutrition 0.000 description 1
- 244000063464 Vitex agnus-castus Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 208000018631 connective tissue disease Diseases 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002497 edematous effect Effects 0.000 description 1
- 210000002310 elbow joint Anatomy 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 208000028331 flaccid paralysis Diseases 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000000811 metacarpophalangeal joint Anatomy 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 208000005987 polymyositis Diseases 0.000 description 1
- 238000010837 poor prognosis Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 201000010727 rectal prolapse Diseases 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 230000036301 sexual development Effects 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗皮肌炎的中药制剂及其制备方法,由以下重量份的原料组成:柴胡10‑15份,葛根10‑20份,元参10‑15份,赤芍10‑20份,金银花20‑30份,连翘10‑15份,甘草8‑10份,石膏20‑40份,蒺藜10‑15份,白癣皮10‑15份,荆芥10‑15份,防风10‑20份;本发明以和解表里、疏肝解郁的柴胡为君药,以解肌退热透疹的葛根和泻火解毒的元参为臣药,配伍合理,无毒副作用,清热解毒、祛风透疹,能够快速治愈皮肌炎,标本兼治,且不易复发,无毒副作用。
Description
技术领域
本发明涉及中药技术领域,尤其是涉及一种治疗皮肌炎的中药制剂及其制备方法。
背景技术
皮肌炎是一种以皮肤、肌肉损害为突出表现的自身免疫性结缔组织病。以受累皮肤(面颈部、眼周等部位〕淡紫红色水肿性红斑,肌痛、肌无力等为主要临床特征。病变也可累及全身其他脏器,只侵犯肌肉而无皮肤损害者,称为多发性肌炎。临床上以对称性肢带肌、颈肌及咽肌无力为特征,常累及多种脏器,亦可伴发肿瘤和其他结缔组织病。发病原因一般认为与遗传和病毒感染有关。通常隐袭起病,在数周、数月、数年内缓慢进展。极少数患者急性起病,在数日内出现严重肌无力,甚或横纹肌溶解、肌球蛋白尿和肾功能衰竭。患者可有晨僵、乏力、食欲不振、体重减轻、发热(中低度热,甚至高热)、关节疼痛,少数患者有雷诺现象。
皮肌炎可发生于任何年龄,发病高峰儿童在5~15岁,成人在30~50岁,女性略多于男性。发病可能与肿瘤、感染、药物、内分泌、代谢等因素有关。皮肌炎大部分呈慢性进行性发展,预后良好,2~3年内可恢复正常,少部分急性发作者,常因并发感染死亡,并发肿瘤者,也预后极差。该病属慢性疾病,病程较长,西医常采用糖皮质激素和免疫抑制剂进行治疗,疗效取决于疾病的类型、治疗方案、患者和家属的积极配合,疗程非常长,达1~2年之久,激素类药物以及免疫抑制剂对人体有较大的毒副作用。
发明内容
有鉴于此,本发明的目的是针对现有技术的不足,提供一种治疗皮肌炎的中药制剂及其制备方法,对辨证为眼睑红斑水肿、面部红色斑疹、皮疹呈对称性的皮肌炎能够快速治愈,标本兼治,且不易复发,无毒副作用。
为达到上述目的,本发明采用以下技术方案:
一种治疗皮肌炎的中药制剂,由以下重量份的原料组成:柴胡10-15份,葛根10-20份,元参10-15份,赤芍10-20份,金银花20-30份,连翘10-15份,甘草8-10份,石膏20-40份,蒺藜10-15份,白癣皮10-15份,荆芥10-15份,防风10-20份。
进一步的,一种治疗皮肌炎的中药制剂,由以下重量份的原料组成:柴胡13-15份,葛根12-17份,元参12-14份,赤芍12-16份,金银花26-28份,连翘13-14份,甘草8-10份,石膏21-30份,蒺藜12-13份,白癣皮13-15份,荆芥13-15份,防风15-17份。
进一步的,一种治疗皮肌炎的中药制剂,由以下重量份的原料组成:柴胡12份,葛根10份,元参15份,赤芍18份,金银花24份,连翘12份,甘草8份,石膏33份,蒺藜13份,白癣皮12份,荆芥12份,防风13份。
本发明还提供了一种治疗皮肌炎的中药制剂胶囊的制备方法,包括以下步骤:
1)按照所述的治疗皮肌炎的中药制剂的原料配比称取炒柴胡、葛根、元参、赤芍、金银花、连翘、甘草、石膏、蒺藜、白癣皮、荆芥和防风,整理除杂后干燥;
2)将步骤1)干燥后的药材混合均匀后研磨成粉,过筛后在紫外杀菌灯灯光下灭菌2.5小时;
3)将步骤2)灭菌后的中药粉装入空胶囊中制成中药胶囊。
进一步的,该制备方法步骤2)所述的过筛的筛网目数为200-500目。
本发明还提供了一种治疗皮肌炎的中药制剂汤剂的制备方法,包括以下步骤:
1)按照所述的治疗皮肌炎的中药制剂的原料配比称取炒柴胡、葛根、元参、赤芍、金银花、连翘、甘草、石膏、蒺藜、白癣皮、荆芥和防风,整理除杂后放入砂锅浸泡半小时;
2)将步骤1)中盛装中药药材和水的砂锅用武火煮沸,转用文火慢煮半小时,关火自然冷却至60-70℃,经滤网布过滤后得到一次药液;
3)将经过步骤2)处理后剩余的中药药渣中加水,武火煮沸后转用文火慢煮15分钟,关火自然冷却至60-70℃,经滤网布过滤后得到二次药液;
4)将步骤2)和步骤3)中得到的一次药液和二次药液混合,并搅拌均匀,自然冷却至室温后封装,得中药药液制剂。
上述方法制备的为中药汤剂,本中药汤剂的服用方法为:1天分三次服用。也可1次性煎煮2天的药量,将制得的药液杀菌后灌装密封,在冰箱保鲜区以0-5℃冷藏,服用时先微加热即可。
该中药制剂可以制备成中药片剂、颗粒、药丸等多种形式,并不局限为汤剂和胶囊,适用于多种治疗方式,用药方式。
本发明中的各类中药的药性药理如下:
柴胡:味辛、苦,性微寒;归肝、胆、肺经;和解表里,疏肝解郁,升阳举陷,退热截疟;用于感冒发热,寒热往来,胸胁胀痛,月经不调,子宫脱垂,脱肛。
葛根:味甘、辛,性凉;归肺、胃经;功效:解肌退热,透疹,生津止渴,升阳止泻;主治:用于表证发热,项背强痛,麻疹不透,热病口渴,阴虚消渴,热泻热痢,脾虚泄泻。
元参:味甘;苦;咸;性微寒;归肺;胃;肾经;功效、应用:清热凉血、养阴清热、泻火解毒、软坚散结,凉血滋阴,泻火解毒,发烧烦渴,自汗盗汗,便秘,吐血鼻血,咽喉炎,肺结核;用于热病伤阴、舌绛烦渴、温毒发斑、津伤便秘、骨蒸劳嗽、目赤、咽痛、瘰疬、白喉、痈肿疮毒。
赤芍:味苦,性微寒;归肝经;清热凉血,散瘀止痛;用于热人营血,温毒发斑,吐血衄血,目赤肿痛,肝郁胁痛,经闭痛经,瘾瘕腹痛,跌扑损伤,痈肿疮疡。
金银花:金银花性寒,味甘,入肺、心、胃经,具有清热解毒、抗炎、补虚疗风的功效,主治胀满下疾、温病发热,热毒痈疡和肿瘤等症;其对于头昏头晕、口干作渴、多汗烦闷、肠炎、菌痢、麻疹、肺炎、乙脑、流脑、急性乳腺炎、败血症、阑尾炎、皮肤感染、痈疽疔疮、丹毒、腮腺炎、化脓性扁桃体炎等病症均有一定疗效。
连翘:中药味苦,性微寒;清热解毒,散结消肿;蒙药味苦,性凉;清“协日”,止泻;主治:中药治热病初起,风热感冒,发热,心烦,咽喉肿痛,斑疹,丹毒,瘰疬,痈疮肿毒,急性肾炎,热淋;蒙药治黄疸,肠刺痛,“协日”病,肠热;连翘是清热解毒的中药,主治热病初起,风热感冒,发热,心烦,咽喉肿痛,急性肾炎等。
甘草:味甘,性平;归心、肺、脾、胃经;功效:补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药;主治:用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹、四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性。
石膏:辛甘,寒;入胃经、肺经;功效:清热泻火,除烦止渴,收敛生肌;主治:中风寒热,心下逆气惊喘,口干舌焦,不能息,腹中坚痛,除邪鬼,产褥金疮;除时气头痛身热,三焦大热,皮肤热,肠胃中结气,解肌发汗,止消渴烦逆,腹胀暴气,喘息咽热,亦可做浴汤;治伤寒头疼如裂;和葱煎茶,去头疼;治天行狂热,头风旋,下乳,揩齿益齿;除胃热肺热,散阴邪,缓脾益气;止阳明经头疼,发热恶寒,日哺潮热,大渴引饮,中暑潮热,牙疼。
蒺藜:辛、苦,微温;有小毒;归肝经;苦、温、无毒;主要药物疗效为平肝解郁,活血祛风,明目,止痒;去风下气,行水化症之药也;其性宣通快便,能运能消,行肝脾滞气,多服久服蒺藜,有去滞之功。
白癣皮:性味:苦咸,寒;入脾、胃经;功能主治:清热燥湿,祛风解毒,用于湿热疮毒,黄水淋漓,湿疹,风疹,疥癣疮瘌,风湿热痹,黄疸尿赤。
荆芥:味辛;微苦;性微温;入肺、肝经;功效主治:祛风;解表;透疹;止血;主感冒发热;头痛;目痒;咳嗽;咽喉肿痛;麻疹;痈肿;疮疥;衄血;吐血;便血;崩漏;产后血晕;用于感冒,头痛,麻疹,风疹,疮疡初起;炒炭治便血,崩漏,产后血晕;解表散风,透疹,消疮,止血;用于感冒,麻疹透发不畅,便血、崩漏、鼻衄。
防风:性味:辛、甘,温;归经:归膀胱、肝、脾经;功效:祛风解表、胜湿止痛、解痉、止痒;主治:外感风寒;头痛身痛;风湿痹痛;骨节酸痛;腹痛泄泻;肠风下血;破伤风;风疹瘙痒;疮疡初起;功效分类:解表药;祛风药。
本发明遵循中医“君臣佐使”的组方原则,全部成分来自于中国《药典》第五版收载的药物,选用的中药各组份符合中华人民共和国药品管理法之规定,利用各味中药的综合作用,对人体无毒无害。经小白鼠和大白鼠的急性毒性试验和蓄积性毒性试验表明被试验的动物未见任何毒性反应,经解剖观察血象、肝功能、各脏器组织形态学所见与对照组比较无差异,证明其药物安全可靠。
中医学认为皮肌炎属痿症范畴,亦有认为与肌痹、风痿痹相似,可属痹证范畴。一般认为,本病在发病过程中以皮损为主症者,应以皮肤红斑论治;如以四肢肌肉疼痛为主,则以痹证论治;若以肌肉无力为主者,应以痿证论治;若病变向深重发展,形体受损延及内脏者则可按虚损论治。中医认为多因先天禀赋不足,或情志内伤,气血逆乱,以致机体卫外失固,复感风寒湿邪,邪蕴肌肤,痹阻经络,郁而化热,而致皮肤红斑,肌肉疼痛;邪内传于脾,脾气受损则四肢肌肉无力;或因风湿毒邪侵袭,蕴阻肌肤,内传营血,热毒炽盛,气血两燔而引起急性发作;久病阴阳气血失调,脏气受损,出现心脾两虚或阳虚血淤等证。其急性期主要是热毒或寒湿为患,缓解期则多累及肝、脾、肾三脏。
本发明以和解表里、疏肝解郁的柴胡为君药,以解肌退热透疹的葛根和泻火解毒的元参为臣药,以清热解毒的赤芍、金银花、连翘、甘草、石膏、以及活血祛风的蒺藜、祛风解毒的白癣皮、祛风解表透疹止血的荆芥为佐药,以祛风解表的防风为使药,配伍合理,无毒副作用,清热解毒、祛风透疹,能够快速治愈皮肌炎,标本兼治,且不易复发,无毒副作用。
具体实施方式
下面结合实施例对本发明作进一步描述。
实施例1
一种治疗皮肌炎的中药制剂,由以下重量份的原料组成:柴胡10份,葛根20份,元参14份,赤芍16份,金银花22份,连翘10份,甘草10份,石膏40份,蒺藜13份,白癣皮12份,荆芥10份,防风10份。
本实施例还提供了本中药制剂胶囊的制备方法,包括以下步骤:
1)按照所述的治疗皮肌炎的中药制剂的原料配比称取炒柴胡、葛根、元参、赤芍、金银花、连翘、甘草、石膏、蒺藜、白癣皮、荆芥和防风,整理除杂后干燥;
2)将步骤1)干燥后的药材混合均匀后研磨成粉,过300目筛后在紫外杀菌灯灯光下灭菌2.5小时;
3)将步骤2)灭菌后的中药粉装入空胶囊中制成中药胶囊。
上述方法制备的为中药胶囊,其服用方法为,每日分早晚两次服用,每次5粒。
实施例2
一种治疗皮肌炎的中药制剂,由以下重量份的原料组成:柴胡12份,葛根10份,元参15份,赤芍18份,金银花24份,连翘12份,甘草8份,石膏33份,蒺藜13份,白癣皮12份,荆芥12份,防风13份。
本实施例还提供了本中药制剂汤剂的制备方法,包括以下步骤:
1)将上述重量份的炒柴胡、葛根、元参、赤芍、金银花、连翘、甘草、石膏、蒺藜、白癣皮、荆芥和防风,整理除杂后放入砂锅,注入1200ml的清水浸泡半小时;
2)将步骤1)中盛装中药药材和水的砂锅用武火煮沸,转用文火慢煮半小时,关火自然冷却至60-70℃,经滤网布过滤后得到一次药液;
3)将经过步骤2)处理后剩余的中药药渣中加水,武火煮沸后转用文火慢煮15分钟,关火自然冷却至60-70℃,经滤网布过滤后得到二次药液;
4)将步骤2)和步骤3)中得到的一次药液和二次药液混合,得到约600ml药液制剂,并搅拌均匀,自然冷却至室温后封装,得中药药液制剂。
上述方法制备的为中药汤剂,其服用方法为:一日三次服用,也可1次性煎煮2天的药量,将制得的药液杀菌后灌装密封,在冰箱保鲜区以0-5℃冷藏,服用时先微加热即可。
实施例3
一种治疗皮肌炎的中药制剂,由以下重量份的原料组成:柴胡13份,葛根12份,元参10份,赤芍20份,金银花26份,连翘12份,甘草9份,石膏21份,蒺藜15份,白癣皮13份,荆芥12份,防风15份。
本实施例还提供了本中药制剂汤剂的制备方法,包括以下步骤:
1)将上述重量份的炒柴胡、葛根、元参、赤芍、金银花、连翘、甘草、石膏、蒺藜、白癣皮、荆芥和防风,整理除杂后放入砂锅,注入1200ml的清水浸泡半小时;
2)将步骤1)中盛装中药药材和水的砂锅用武火煮沸,转用文火慢煮半小时,关火自然冷却至60-70℃,经滤网布过滤后得到一次药液;
3)将经过步骤2)处理后剩余的中药药渣中加水,武火煮沸后转用文火慢煮15分钟,关火自然冷却至60-70℃,经滤网布过滤后得到二次药液;
4)将步骤2)和步骤3)中得到的一次药液和二次药液混合,得到约600ml药液制剂,并搅拌均匀,自然冷却至室温后封装,得中药药液制剂。
上述方法制备的为中药汤剂,其服用方法为:一日三次服用,也可1次性煎煮2天的药量,将制得的药液杀菌后灌装密封,在冰箱保鲜区以0-5℃冷藏,服用时先微加热即可。
实施例4
一种治疗皮肌炎的中药制剂,由以下重量份的原料组成:柴胡13份,葛根15份,元参12份,赤芍12份,金银花28份,连翘13份,甘草9份,石膏25份,蒺藜10份,白癣皮15份,荆芥13份,防风17份。
本实施例还提供了本中药制剂胶囊的制备方法,包括以下步骤:
1)按照所述的治疗皮肌炎的中药制剂的原料配比称取炒柴胡、葛根、元参、赤芍、金银花、连翘、甘草、石膏、蒺藜、白癣皮、荆芥和防风,整理除杂后干燥;
2)将步骤1)干燥后的药材混合均匀后研磨成粉,过400目筛后在紫外杀菌灯灯光下灭菌2.5小时;
3)将步骤2)灭菌后的中药粉装入空胶囊中制成中药胶囊。
上述方法制备的为中药胶囊,其服用方法为,每日分早晚两次服用,每次5粒。
实施例5
一种治疗皮肌炎的中药制剂,由以下重量份的原料组成:柴胡15份,葛根17份,元参13份,赤芍14份,金银花20份,连翘15份,甘草9份,石膏30份,蒺藜12份,白癣皮10份,荆芥15份,防风20份。
本实施例还提供了本中药制剂汤剂的制备方法,包括以下步骤:
1)将上述重量份的炒柴胡、葛根、元参、赤芍、金银花、连翘、甘草、石膏、蒺藜、白癣皮、荆芥和防风,整理除杂后放入砂锅,注入1200ml的清水浸泡半小时;
2)将步骤1)中盛装中药药材和水的砂锅用武火煮沸,转用文火慢煮半小时,关火自然冷却至60-70℃,经滤网布过滤后得到一次药液;
3)将经过步骤2)处理后剩余的中药药渣中加水,武火煮沸后转用文火慢煮15分钟,关火自然冷却至60-70℃,经滤网布过滤后得到二次药液;
4)将步骤2)和步骤3)中得到的一次药液和二次药液混合,得到约600ml药液制剂,并搅拌均匀,自然冷却至室温后封装,得中药药液制剂。
上述方法制备的为中药汤剂,其服用方法为:一日三次服用,也可1次性煎煮2天的药量,将制得的药液杀菌后灌装密封,在冰箱保鲜区以0-5℃冷藏,服用时先微加热即可。
本发明的上述中药制剂进行了毒性试验,试验效果如下:
选取大、小白鼠各20只,雌、雄各半,分为对照组和给药组,体重相当,饲养条件一致,对照组不喂药,给药组每天喂药1次,每天记录各个小白鼠的身体状况、摄食、饮水、体重,试验持续六个月,与对照组相比,给药组小白鼠身体状况、摄食、饮水、体重增长均正常,且未见小白鼠生病或死亡,解剖后也未发现病变。提示该药安全性好,无毒副作用。
本发明同时对所给出的配方进行了临床疗效追踪,疗效汇总如下:
共统计患者93例,年龄28-64岁,平均年龄42岁,有12例效果不明显,治疗有效率为87%,治愈后患者均未发现复发迹象。
本发明的中药制剂的治疗案例如下:
某刘姓患者,男,50岁。眼睑红斑水肿、面部红色斑疹、皮疹呈对称性,疲倦乏力,无规则发热,肌肉疼痛,给于本发明提供的中药,两周后,不再无规则发热,水肿、疲倦以及疼痛等症状减轻,皮疹部分消失,四周后肌肉不再疼痛,水肿、疲倦、皮疹完全消失,精神状态恢复,为巩固治疗,又用药两周。一年后追访,无复发。
某赵性患者,女,36岁。四肢肘关节、膝关节、踝关节以及掌指关节、指间关节伸面有紫红色丘疹,且水肿,肌肉疼痛,西医诊断为皮肌炎,采用抗生素和免疫抑制剂进行治疗,三个月症状未缓解,考虑到西药的毒副作用以及病菌的抗药性,患者到发明人所在的中医院就诊,给于本发明提供的中药,两周后,水肿及疼痛症状减轻,关节伸面处的丘疹有所减少,四周后,水肿及疼痛症状消失,丘疹明显减少,八周后丘疹完全消失。一年后追访,无复发。
某栗性患者,男,37岁。就诊时眼睑及周围的紫红色浮肿性红斑,手指伸侧鳞屑性红斑,四肢无力,轻触痛感强烈,动作迟缓,四肢近端明显肌萎缩。给于本发明提供的中药,一个月后,紫红色浮肿性红斑及疼痛症状减轻,三个月后,疼痛症状消失,四个月后症状完全消失。一年后追访,无复发。
某刘性患者,男,62岁。就诊时,皮肤紫红肿斑,肌肉疼痛,手足无力,因长期一人在家,无人照顾,已近两月仅食流食。给于本发明提供的中药,两周后,紫红肿斑及疼痛症状减轻,八周后症状完全消失。一年后追访,无复发。
某高性患者,男,29岁。就诊时皮肤大片鲜红水肿性斑片,触之疼痛,多发于面部及上胸背部,肌肉关节疼痛无力,伴口干口苦、心悸烦躁、小便短赤、大便秘结。给于本发明提供的中药,7天后,疼痛症状减轻,四周后,水肿性斑片完全消失。半年后追访,无复发。
某朱性患者,男,45岁。患病已两年,就诊时肌肉隐痛,肢体痿软无力,肌肉有萎缩迹象,腰脊酸软,不能久立,常有目眩头晕,脱发耳鸣。给于本发明提供的中药,20天后,可以短距离行走,2月后自由运动,可以做轻微农活。一年后追访,无复发。
可以理解的是,以上关于本发明的具体描述,仅用于说明本发明而并非受限于本发明实施例所描述的技术方案,本领域的普通技术人员应当理解,仍然可以对本发明进行修改或等同替换,以达到相同的技术效果;只要满足使用需要,都在本发明的保护范围之内。
Claims (6)
1.一种治疗皮肌炎的中药制剂,其特征在于:由以下重量份的原料组成:柴胡10-15份,葛根10-20份,元参10-15份,赤芍10-20份,金银花20-30份,连翘10-15份,甘草8-10份,石膏20-40份,蒺藜10-15份,白癣皮10-15份,荆芥10-15份,防风10-20份。
2.根据权利要求1所述的一种治疗皮肌炎的中药制剂,其特征在于:由以下重量份的原料组成:柴胡13-15份,葛根12-17份,元参12-14份,赤芍12-16份,金银花26-28份,连翘13-14份,甘草8-10份,石膏21-30份,蒺藜12-13份,白癣皮13-15份,荆芥13-15份,防风15-17份。
3.根据权利要求1所述的一种治疗皮肌炎的中药制剂,其特征在于:由以下重量份的原料组成:柴胡12份,葛根10份,元参15份,赤芍18份,金银花24份,连翘12份,甘草8份,石膏33份,蒺藜13份,白癣皮12份,荆芥12份,防风13份。
4.一种如权利要求1-3任意一项所述的治疗皮肌炎的中药制剂的制备方法,其特征在于:包括以下步骤:
1)按照所述的治疗皮肌炎的中药制剂的原料配比称取炒柴胡、葛根、元参、赤芍、金银花、连翘、甘草、石膏、蒺藜、白癣皮、荆芥和防风,整理除杂后干燥;
2)将步骤1)干燥后的药材混合均匀后研磨成粉,过筛后在紫外杀菌灯灯光下灭菌2.5小时;
3)将步骤2)灭菌后的中药粉装入空胶囊中制成中药胶囊。
5.根据权利要求4所述的一种治疗皮肌炎的中药制剂的制备方法,其特征在于:步骤2)中,所述的过筛用筛网目数为200-500目。
6.一种如权利要求1-3任意一项所述的治疗皮肌炎的中药制剂的制备方法,其特征在于:包括以下步骤:
1)按照所述的治疗皮肌炎的中药制剂的原料配比称取炒柴胡、葛根、元参、赤芍、金银花、连翘、甘草、石膏、蒺藜、白癣皮、荆芥和防风,整理除杂后放入砂锅浸泡半小时;
2)将步骤1)中盛装中药药材和水的砂锅用武火煮沸,转用文火慢煮半小时,关火自然冷却至60-70℃,经滤网布过滤后得到一次药液;
3)将经过步骤2)处理后剩余的中药药渣中加水,武火煮沸后转用文火慢煮15分钟,关火自然冷却至60-70℃,经滤网布过滤后得到二次药液;
4)将步骤2)和步骤3)中得到的一次药液和二次药液混合,并搅拌均匀,自然冷却至室温后封装,得中药药液制剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711297308.7A CN107898866A (zh) | 2017-12-08 | 2017-12-08 | 一种治疗皮肌炎的中药制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711297308.7A CN107898866A (zh) | 2017-12-08 | 2017-12-08 | 一种治疗皮肌炎的中药制剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107898866A true CN107898866A (zh) | 2018-04-13 |
Family
ID=61853992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711297308.7A Pending CN107898866A (zh) | 2017-12-08 | 2017-12-08 | 一种治疗皮肌炎的中药制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107898866A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103690824A (zh) * | 2012-09-28 | 2014-04-02 | 青岛信立德中药技术研究开发有限公司 | 一种治疗皮肌炎的中药 |
CN106880788A (zh) * | 2015-12-10 | 2017-06-23 | 宋淑芹 | 一种治疗皮肌炎的中药 |
-
2017
- 2017-12-08 CN CN201711297308.7A patent/CN107898866A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103690824A (zh) * | 2012-09-28 | 2014-04-02 | 青岛信立德中药技术研究开发有限公司 | 一种治疗皮肌炎的中药 |
CN106880788A (zh) * | 2015-12-10 | 2017-06-23 | 宋淑芹 | 一种治疗皮肌炎的中药 |
Non-Patent Citations (2)
Title |
---|
常贵祥: "运用解肌法治疗皮肌炎", 《中医研究》 * |
查玉明: "皮肌炎两则治验", 《辽宁中医杂志》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10485842B2 (en) | Chinese herbal oral paste for conditioning yang deficiency constitution and processing method thereof | |
CN104474471A (zh) | 一种治疗甲状腺的中药组合物 | |
CN103816454A (zh) | 一种治疗动脉硬化的纯中药胶囊 | |
CN103919008A (zh) | 具有健脾补肾功能的保健粥及其制备方法 | |
CN102178866B (zh) | 用于气郁、血瘀体质人袪湿活血、软坚散结的中药制剂及其制备方法和应用 | |
CN104524494A (zh) | 一种中药组合物 | |
CN103844164A (zh) | 一种益气补血粥及其制备方法 | |
CN104906268A (zh) | 治疗湿疹的中药外用剂及其制法 | |
CN104666799A (zh) | 软组织损伤活血化瘀药酒及制备方法 | |
CN104173646A (zh) | 治疗气血两虚所致眩晕的中药汤剂及其制备方法 | |
CN107898866A (zh) | 一种治疗皮肌炎的中药制剂及其制备方法 | |
CN103961578A (zh) | 一种治疗神经衰弱的中药药酒 | |
CN103877226B (zh) | 具有滋肝补肾功效的豆腐黄鳝粥品及其制备方法 | |
CN103932318A (zh) | 一种提高男性肾功能的功能性饮料 | |
CN104042872B (zh) | 治疗小儿感冒的中药组合物及其制备方法 | |
CN107854662A (zh) | 一种治疗肝硬化腹水的中药制剂及其制备方法 | |
CN102961628A (zh) | 一种治疗支气管扩张症的中成药 | |
CN106924694A (zh) | 一种治疗习惯性便秘的药物及其制备方法 | |
CN106822852A (zh) | 治疗冠心病的药物组合物、其制备工艺及用途 | |
CN105412383A (zh) | 小儿风寒感冒药浴包 | |
CN105535869A (zh) | 一种可有效治疗噎嗝病的中药组合物及其制备方法 | |
CN105362596A (zh) | 一种治疗肺气肿的中药及其制备方法 | |
CN104984305B (zh) | 一种治疗慢性胆囊炎的中药组合物 | |
CN103623377B (zh) | 一种治疗痹症的药物及其制备方法 | |
CN105031484A (zh) | 一种可治疗血栓性静脉炎的内服药物及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180413 |
|
RJ01 | Rejection of invention patent application after publication |